{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:30:07Z","timestamp":1784557807922,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.jim.2005.03.008","type":"journal-article","created":{"date-parts":[[2005,4,26]],"date-time":"2005-04-26T11:21:48Z","timestamp":1114514508000},"page":"21-30","source":"Crossref","is-referenced-by-count":29,"title":["Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV)"],"prefix":"10.1016","volume":"301","author":[{"given":"Shixia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlo","family":"Sakhatskyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te-Hui W.","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2005.03.008_bib1","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3201\/eid0909.030471","article-title":"Transmission of severe acute respiratory syndrome","volume":"9","author":"Arita","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jim.2005.03.008_bib2","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1073\/pnas.0403492101","article-title":"Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity","volume":"101","author":"Buchholz","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2005.03.008_bib3","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1073\/pnas.94.19.10018","article-title":"A vaccine for HIV type 1: the antibody perspective","volume":"94","author":"Burton","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2005.03.008_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ni0304-233","article-title":"HIV vaccine design and the neutralizing antibody problem","volume":"5","author":"Burton","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jim.2005.03.008_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.vetmic.2004.07.017","article-title":"Wild rabies virus detection by plaque assay from naturally infected brains in different species","volume":"103","author":"Cardoso","year":"2004","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.jim.2005.03.008_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0002-9343(03)00352-8","article-title":"Risk of SARS transmission to persons in close contact with discharged patients","volume":"115","author":"Chan","year":"2003","journal-title":"Am. J. Med."},{"issue":"Pt 5","key":"10.1016\/j.jim.2005.03.008_bib7","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1099\/0022-1317-68-5-1277","article-title":"The effect of antibody on rubella virus infection in human lymphoid cells","volume":"68","author":"Chantler","year":"1987","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jim.2005.03.008_bib8","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2005.03.008_bib9","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.1128\/JVI.77.19.10684-10688.2003","article-title":"Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein","volume":"77","author":"Earl","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2005.03.008_bib10","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1126\/science.301.5641.1824b","article-title":"Infectious diseases. Singapore lab faulted in SARS case","volume":"301","author":"Enserink","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jim.2005.03.008_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/423240a","article-title":"Aetiology: Koch's postulates fulfilled for SARS virus","volume":"423","author":"Fouchier","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jim.2005.03.008_bib12","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1056\/NEJMp030078","article-title":"SARS-associated coronavirus","volume":"348","author":"Holmes","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2005.03.008_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3181\/00379727-128-32947","article-title":"Cross plaque neutralization of 2 antigenically closely related dengue viruses (type 2 New Guinea C and TH-36)","volume":"128","author":"Ibrahim","year":"1968","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.jim.2005.03.008_bib14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(03)13874-3","article-title":"SARS transmission: language and droplet production","volume":"362","author":"Inouye","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2005.03.008_bib15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000148856","article-title":"Studies on a heat-labile variola virus inhibitor in normal sera. I. Detection by the variola focus reduction assay and its general characteristics","volume":"1","author":"Kitamura","year":"1973","journal-title":"Intervirology"},{"key":"10.1016\/j.jim.2005.03.008_bib16","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2005.03.008_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(03)13967-0","article-title":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome","volume":"362","author":"Kuiken","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2005.03.008_bib18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM200307313490520","article-title":"Profile of specific antibodies to the SARS-associated coronavirus","volume":"349","author":"Li","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2005.03.008_bib19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jim.2005.03.008_bib20","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1128\/JVI.73.7.6024-6030.1999","article-title":"Ebola virus can be effectively neutralized by antibody produced in natural human infection","volume":"73","author":"Maruyama","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2005.03.008_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-3542(88)90066-6","article-title":"Mismatched dsRNA (ampligen) induces protection against genomic variants of the human immunodeficiency virus type 1 (HIV-1) in a multiplicity of target cells","volume":"9","author":"Montefiori","year":"1988","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.jim.2005.03.008_bib21","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1128\/JVI.72.3.1886-1893.1998","article-title":"Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage","volume":"72","author":"Montefiori","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2005.03.008_bib23","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1128\/JCM.41.7.3154-3157.2003","article-title":"Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine","volume":"41","author":"Newman","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2005.03.008_bib24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.304.5671.659","article-title":"Infectious diseases. Mounting lab accidents raise SARS fears","volume":"304","author":"Normile","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jim.2005.03.008_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1126\/science.303.5654.26","article-title":"Infectious diseases. Second lab accident fuels fears about SARS","volume":"303","author":"Normile","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jim.2005.03.008_bib26","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1126\/science.304.5675.1223a","article-title":"Severe acute respiratory syndrome: lab accidents prompt calls for new containment program","volume":"304","author":"Normile","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jim.2005.03.008_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/infdis\/155.1.146","article-title":"The plaque-neutralization test as a measure of prior exposure to measles virus","volume":"155","author":"Orenstein","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2005.03.008_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/427185a","article-title":"Antibodies to SARS-like virus hint at repeated infections","volume":"427","author":"Pearson","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jim.2005.03.008_bib29","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2005.03.008_bib30","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa030634","article-title":"Identification of severe acute respiratory syndrome in Canada","volume":"348","author":"Poutanen","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2005.03.008_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/10810730305722","article-title":"Putting SARS in perspective: a communication challenge","volume":"8","author":"Ratzan","year":"2003","journal-title":"J. Health Commun."},{"key":"10.1016\/j.jim.2005.03.008_bib32","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3181\/00379727-125-32157","article-title":"Cytopathic and plaque assay of rubella virus in a line of African green monkey kiency cells (Vero)","volume":"125","author":"Rhim","year":"1967","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.jim.2005.03.008_bib33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1749-6632.2001.tb02704.x","article-title":"Antibody prophylaxis and therapy for flavivirus encephalitis infections","volume":"951","author":"Roehrig","year":"2001","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.jim.2005.03.008_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4049\/jimmunol.99.2.291","article-title":"Dengue virus identification by the plaque reduction neutralization test","volume":"99","author":"Russell","year":"1967","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2005.03.008_bib35","doi-asserted-by":"crossref","first-page":"882","DOI":"10.4065\/78.7.882","article-title":"SARS: epidemiology, clinical presentation, management, and infection control measures","volume":"78","author":"Sampathkumar","year":"2003","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jim.2005.03.008_bib36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/jcm.9.2.259-265.1979","article-title":"Sensitive neutralization test for rubella antibody","volume":"9","author":"Sato","year":"1979","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2005.03.008_bib37","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1073\/pnas.0307140101","article-title":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association","volume":"101","author":"Sui","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2005.03.008_bib38","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM200408053510619","article-title":"Evidence of airborne transmission of SARS","volume":"351","author":"Tong","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2005.03.008_bib39","first-page":"167","article-title":"Comparison of five methods for the detection of measles specific immunoglobulin G antibody","volume":"38","author":"Vazquez-Rosales","year":"1996","journal-title":"Rev. Latinoam. Microbiol."},{"key":"10.1016\/j.jim.2005.03.008_bib40","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/JVI.79.3.1906-1910.2005","article-title":"Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system","volume":"79","author":"Wang","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2005.03.008_bib41","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0140-6736(04)16344-7","article-title":"SARS under control, but lab-safety questions remain","volume":"363","author":"Watts","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2005.03.008_bib42","first-page":"271","article-title":"Application of the plaque assay technique to the study of rabies virus-neutralizing antibody interactions","volume":"124","author":"Wiktor","year":"1973","journal-title":"Ann. Microbiol. (Paris)"},{"key":"10.1016\/j.jim.2005.03.008_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF01250244","article-title":"An improvement in the plaque assay of rabies virus in chick embryo cells","volume":"34","author":"Yoshino","year":"1971","journal-title":"Arch. Gesamte Virusforsch."},{"key":"10.1016\/j.jim.2005.03.008_bib44","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.bbrc.2004.01.166","article-title":"Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS\u2013CoV spike gene fragments","volume":"315","author":"Zeng","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175905000839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175905000839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T01:44:27Z","timestamp":1683078267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175905000839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":44,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0022175905000839"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2005.03.008","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}